1 / 5

Biosimilars Market Overview in 2015 Research Report

Complete report @ http://goo.gl/7XXo6x "Biosimilars on the Cusp of a New Era" report provides an overview and background about biosimilars – what they are and a timeline of their development and key concerns regarding the development and use of biosimilars.

jamesmarsh
Download Presentation

Biosimilars Market Overview in 2015 Research Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biosimilars Market Research Report 2015 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. Published: April 2015 Single User PDF: US$ 2995 Corporate User PDF: US$ 8985 © ReportsnReports.com / Contact sales@reportsandreports.com

  2. Biosimilars Market Research Report 2015 The biosimilars market is undergoing rapid change with developments such as the recent approvals of infliximab and trastuzumab heralding a new era. In order to keep up with the pace of change in the marketplace, regulatory agencies have been developing updated guidance around the development and approval of biosimilars, but there is still a lack of consistency, particularly between the two leading agencies – the FDA and EMA. Moreover, there are some concerns around biosimilar use, for example with physicians worried about how similar certain drugs are and whether they can safely be used in particular patient populations such as transplant, due to the potential for variance in efficacy and tolerability. Despite this, it is expected that the biosimilar market will continue to experience significant growth in the next five to ten years, being driven by the extensive pipeline and the number of companies becoming involved in this area – including some big pharma who are seizing the opportunity to develop biosimilar versions of competitor products in order to ensure they are able to compete at all levels. Single User License Available US $2995 Order a copy of this report at @http://www.reportsnreports.com/purchase.aspx?name=384594. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  3. Biosimilars Market Research Report 2015 Scope The report covers the following key areas An overview and background about biosimilars – what they are and a timeline of their development Key concerns regarding the development and use of biosimilars An overview of the issues around automatic substitution with biosimilars The regulatory landscape for biosimilars, including a comparison of FDA and EMA guidelines Recent developments in the biosimilars market including the anticipated patent expiries of key biologic products and launches of new biosimilar products The position of HTA and P&R agencies on biosimilars Industry perspective on the expected impact of biosimilars The biosimilars pipeline and key future developments Key companies involved in biosimilars The way forward for industry Inquiry Before Buying on this Report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=384594. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  4. Biosimilars Market Research Report 2015 Reasons To Buy The report will: Provide an in-depth insight into recent biosimilar regulatory developments including a comparison of the processes used in different markets and the guidance being implemented Assess the biosimilars pipeline including where development is currently focused and the potential impact new biosimilars will have on the marketplace Highlight industry opinions towards biosimilars and their expected impact in different therapy areas and how industry can meet the challenges being presented by biosimilar development and launches Provide an understanding about the key concerns around biosimilar development and use, including manufacturing concerns and issues around automatic substitution Provide an overview of the key companies involved in the biosimilar market including an analysis of where the majority of biosimilar companies are located, the markets in which they operate and the future outlook Inquire for Discount @http://www.reportsnreports.com/contacts/discount.aspx?name=384594. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  5. Biosimilars Market Research Report 2015 Table of Contents Executive summary Methodology Biosimilars: an overview Key concerns surrounding biosimilar use Automatic substitution A changing regulatory landscape EMA guidelines FDA guidelines Considerations for the rest of the world Recent developments in the biosimilars market New biosimilar launches Government/agency opinions Implications for the marketplace The future outlook The biosimilar pipeline Paradigm-changing potential Key players The way forward for industry Appendix Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

More Related